- $28.11m
- $19.63m
- $85.90m
- 40
- 74
- 96
- 80
Annual income statement for EMCORE, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 110 | 158 | 45.3 | 97.7 | 85.9 |
| Cost of Revenue | |||||
| Gross Profit | 35.6 | 61.5 | 4.07 | 23.4 | 18.8 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 117 | 133 | 86.4 | 146 | 111 |
| Operating Profit | -7.03 | 25.5 | -41 | -48.7 | -25.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.94 | 26.2 | -40.9 | -49.4 | -26.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7 | 25.6 | -40.8 | -49.4 | -26.9 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -7 | 25.6 | -24.3 | -75.4 | -31.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7 | 25.6 | -24.3 | -75.4 | -31.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.91 | 5.51 | -9.33 | -6.34 | -2.33 |